Minhee Won

9.7k total citations · 1 hit paper
63 papers, 3.5k citations indexed

About

Minhee Won is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Minhee Won has authored 63 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Genetics, 36 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Minhee Won's work include Glioma Diagnosis and Treatment (52 papers), Brain Metastases and Treatment (29 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). Minhee Won is often cited by papers focused on Glioma Diagnosis and Treatment (52 papers), Brain Metastases and Treatment (29 papers) and Radiomics and Machine Learning in Medical Imaging (10 papers). Minhee Won collaborates with scholars based in United States, Canada and Israel. Minhee Won's co-authors include Minesh P. Mehta, Rachelle Lanciano, Gerald E. Hanks, Walter J. Curran, Mark R. Gilbert, Lawrence R. Coia, Deborah T. Blumenthal, Terri S. Armstrong, Christopher J. Schultz and Jeffrey S. Wefel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Minhee Won

59 papers receiving 3.4k citations

Hit Papers

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma:... 2013 2026 2017 2021 2013 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
    2013 742 citations Mark R. Gilbert, Meihua Wang et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minhee Won United States 26 2.0k 1.4k 643 560 530 63 3.5k
Michel Fabbro France 34 778 0.4× 723 0.5× 343 0.5× 658 1.2× 511 1.0× 187 3.1k
Chang‐Ok Suh South Korea 38 889 0.5× 1.3k 0.9× 572 0.9× 433 0.8× 930 1.8× 250 4.8k
Vinai Gondi United States 31 2.2k 1.1× 3.2k 2.3× 834 1.3× 368 0.7× 260 0.5× 135 4.5k
Ufuk Abacıoğlu Türkiye 25 2.6k 1.3× 2.8k 2.1× 1.0k 1.6× 409 0.7× 402 0.8× 66 4.4k
Carmen Balañá Spain 25 1.2k 0.6× 848 0.6× 248 0.4× 839 1.5× 644 1.2× 119 2.7k
Frank Saran United Kingdom 34 3.7k 1.9× 1.8k 1.3× 884 1.4× 1.2k 2.2× 985 1.9× 149 6.2k
Marina Paola Gardiman Italy 29 1.2k 0.6× 834 0.6× 504 0.8× 992 1.8× 809 1.5× 92 2.9k
Urs M. Lütolf Switzerland 26 1.1k 0.6× 1.4k 1.0× 267 0.4× 715 1.3× 635 1.2× 50 3.4k
Mary Malec United States 24 1.9k 1.0× 969 0.7× 471 0.7× 718 1.3× 447 0.8× 34 3.0k
Ryma Benayed United States 33 398 0.2× 2.1k 1.6× 296 0.5× 1.0k 1.9× 1.1k 2.1× 85 4.0k

Countries citing papers authored by Minhee Won

Since Specialization
Citations

This map shows the geographic impact of Minhee Won's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minhee Won with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minhee Won more than expected).

Fields of papers citing papers by Minhee Won

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minhee Won. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minhee Won. The network helps show where Minhee Won may publish in the future.

Co-authorship network of co-authors of Minhee Won

This figure shows the co-authorship network connecting the top 25 collaborators of Minhee Won. A scholar is included among the top collaborators of Minhee Won based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minhee Won. Minhee Won is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Omuro, Antonio, Lisa M. DeAngelis, Mei‐Yin C. Polley, et al.. (2025). Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma. Neuro-Oncology. 28(2). 371–382.
2.
Fleming, Jessica L., Edward G. Shaw, Jan C. Buckner, et al.. (2024). Clinical Endpoints Correlation with Molecular Features in the NRG Oncology/RTOG 9802 Low-Grade Glioma, Low-Risk Observation Arm. International Journal of Radiation Oncology*Biology*Physics. 120(2). S214–S214.
3.
Sloan, Andrew E., Kathryn Winter, Mark R. Gilbert, et al.. (2024). NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma. Neuro-Oncology. 26(9). 1628–1637. 11 indexed citations
4.
Lassman, Andrew B., Khê Hoang‐Xuan, Mei‐Yin C. Polley, et al.. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. Journal of Clinical Oncology. 40(23). 2539–2545. 43 indexed citations
5.
Rogers, Leland, Minhee Won, Michael A. Vogelbaum, et al.. (2019). High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539. International Journal of Radiation Oncology*Biology*Physics. 106(4). 790–799. 114 indexed citations
6.
Ali, Arif N., Peixin Zhang, W.K. Alfred Yung, et al.. (2018). NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. Journal of Neuro-Oncology. 137(1). 39–47. 25 indexed citations
7.
Wang, Meihua, James J. Dignam, Minhee Won, et al.. (2015). Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525. Neuro-Oncology. 17(7). 999–1006. 16 indexed citations
8.
Lassman, Andrew B., Stephanie L. Pugh, Mark R. Gilbert, et al.. (2015). Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Neuro-Oncology. 17(7). 992–998. 106 indexed citations
9.
Gilbert, Mark R., Meihua Wang, Kenneth Aldape, et al.. (2013). Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial. Journal of Clinical Oncology. 31(32). 4085–4091. 742 indexed citations breakdown →
10.
Chinnaiyan, Prakash, Minhee Won, Patrick Y. Wen, et al.. (2013). RTOG 0913: A phase I study of daily everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.. Journal of Clinical Oncology. 31(15_suppl). 2047–2047. 1 indexed citations
11.
Wefel, Jeffrey S., Stephanie L. Pugh, Terri S. Armstrong, et al.. (2013). Neurocognitive function (NCF) outcomes in patients with glioblastoma (GBM) enrolled in RTOG 0825.. Journal of Clinical Oncology. 31(15_suppl). 2004–2004. 14 indexed citations
12.
Chinnaiyan, Prakash, Minhee Won, Patrick Y. Wen, et al.. (2013). RTOG 0913: A Phase 1 Study of Daily Everolimus (RAD001) in Combination With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 86(5). 880–884. 56 indexed citations
13.
Sulman, Erik P., Minhee Won, Deborah T. Blumenthal, et al.. (2013). Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in patients with newly diagnosed glioblastoma (GBM).. Journal of Clinical Oncology. 31(15_suppl). LBA2010–LBA2010. 14 indexed citations
14.
Blumenthal, Deborah T., Minhee Won, Minesh P. Mehta, et al.. (2008). Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group Database. Journal of Clinical Oncology. 27(5). 733–739. 80 indexed citations
15.
Drzymala, Robert E., Todd H. Wasserman, Minhee Won, et al.. (2008). A phase I-B trial of the radiosensitizer: Etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). Radiotherapy and Oncology. 87(1). 89–92. 14 indexed citations
16.
Robins, H. Ian, Minhee Won, Wendy Seiferheld, et al.. (2006). Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-00211. Neuro-Oncology. 8(1). 47–52. 48 indexed citations
17.
Fisher, Barbara, Minhee Won, David Macdonald, Douglas Johnson, & Wilson Roa. (2002). Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group 9513. International Journal of Radiation Oncology*Biology*Physics. 53(4). 980–986. 51 indexed citations
18.
Lanciano, Rachelle, Minhee Won, & Gerald E. Hanks. (1992). A reappraisal of the international federation of gynecology and obstetrics staging system for cervical cancer. A study of patterns of care. Cancer. 69(2). 482–487. 37 indexed citations
19.
Lanciano, Rachelle, Minhee Won, Lawrence R. Coia, & Gerald E. Hanks. (1991). Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies. International Journal of Radiation Oncology*Biology*Physics. 20(4). 667–676. 279 indexed citations
20.
Lawton, C.A., Minhee Won, M.V. Pilepich, et al.. (1990). Evaluation of significant late morbidity from external beam irradiation for adenocarcinoma of the prostate (Analysis from RTOG Studies 7506 and 7706). International Journal of Radiation Oncology*Biology*Physics. 19. 199–199. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Fabbro Breakdown of academic impact, for papers by Chang‐Ok Suh Breakdown of academic impact, for papers by Vinai Gondi Breakdown of academic impact, for papers by Ufuk Abacıoğlu Breakdown of academic impact, for papers by Carmen Balañá Breakdown of academic impact, for papers by Frank Saran Breakdown of academic impact, for papers by Marina Paola Gardiman Breakdown of academic impact, for papers by Urs M. Lütolf Breakdown of academic impact, for papers by Mary Malec Breakdown of academic impact, for papers by Ryma Benayed
Rankless by CCL
2026